review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1004738326 |
P356 | DOI | 10.1007/S11481-012-9414-8 |
P932 | PMC publication ID | 4279719 |
P698 | PubMed publication ID | 23114889 |
P50 | author | Carol A. Colton | Q87122812 |
P2860 | cites work | Type I interferon receptor signalling is induced during demyelination while its function for myelin damage and repair is redundant | Q83142663 |
The surface topography of the choroid plexus. Environmental, low and high vacuum scanning electron microscopy | Q83785535 | ||
The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide | Q21090025 | ||
Lipid accumulation and dendritic cell dysfunction in cancer | Q23912213 | ||
ITIM-dependent endocytosis of CD33-related Siglecs: role of intracellular domain, tyrosine phosphorylation, and the tyrosine phosphatases, Shp1 and Shp2 | Q24298136 | ||
MHC class I modulates NMDA receptor function and AMPA receptor trafficking | Q24622132 | ||
Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions | Q24626122 | ||
CNS immune privilege: hiding in plain sight | Q24642697 | ||
Quantitative PCR for detection of the OT-1 transgene | Q24812117 | ||
Myeloid-derived suppressor cells as regulators of the immune system | Q28131637 | ||
IL-10 blocks the development of resistance to re-infection with Schistosoma mansoni | Q28476429 | ||
Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection | Q28482160 | ||
Dendritic cell chemotaxis and transendothelial migration are induced by distinct chemokines and are regulated on maturation | Q77714959 | ||
Dendritic cells and immune responses in the central nervous system | Q77867277 | ||
Cerebrospinal fluid affects phenotype and functions of myeloid dendritic cells | Q78031857 | ||
Type I interferons as anti-inflammatory mediators | Q80180835 | ||
Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response | Q80209390 | ||
Blood monocyte subsets differentially give rise to CD103+ and CD103- pulmonary dendritic cell populations | Q80752326 | ||
Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses | Q81305086 | ||
Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo | Q81309388 | ||
Dysregulation of the inflammatory response to the parasite, Toxoplasma gondii, in P2X7 receptor-deficient mice | Q82280464 | ||
The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues | Q28510383 | ||
IRF-7 is the master regulator of type-I interferon-dependent immune responses | Q28511410 | ||
Genome-wide association study of Alzheimer's disease | Q29417071 | ||
How regulatory T cells work | Q29614262 | ||
Mechanisms of foxp3+ T regulatory cell-mediated suppression | Q29615842 | ||
Fate mapping analysis reveals that adult microglia derive from primitive macrophages | Q29616177 | ||
Development of monocytes, macrophages, and dendritic cells | Q29616446 | ||
A lineage of myeloid cells independent of Myb and hematopoietic stem cells | Q29620147 | ||
Regulatory T cells: mechanisms of differentiation and function | Q29620731 | ||
Immunosuppressive strategies that are mediated by tumor cells | Q29636247 | ||
Regulatory T cells in CNS injury: the simple, the complex and the confused | Q30424827 | ||
Immunological alterations mediated by adenosine during host-microbial interactions | Q30426800 | ||
Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells | Q30873503 | ||
Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement | Q33265418 | ||
The puzzle of intestinal lamina propria dendritic cells and macrophages | Q33349815 | ||
Caspases and nitric oxide broadly regulate dendritic cell maturation and surface expression of class II MHC proteins | Q33581801 | ||
Autoimmune T cell responses in the central nervous system | Q33620003 | ||
Innate and adaptive immune responses can be beneficial for CNS repair | Q33659759 | ||
Molecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy | Q33753720 | ||
Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. | Q33756218 | ||
Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism. | Q33763653 | ||
Antiviral immune responses: triggers of or triggered by autoimmunity? | Q33789445 | ||
Indirect inhibition of Toll-like receptor and type I interferon responses by ITAM-coupled receptors and integrins. | Q33822008 | ||
The myeloid cells of the central nervous system parenchyma | Q34024675 | ||
Peyer's patch dendritic cells sample antigens by extending dendrites through M cell-specific transcellular pores | Q34029747 | ||
Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo | Q34049368 | ||
Dendritic cells (I): Biological functions. | Q34177341 | ||
Interferon-β exacerbates Th17-mediated inflammatory disease | Q34181184 | ||
Cell resilience in species life spans: a link to inflammation? | Q34187140 | ||
Expression of αvβ8 integrin on dendritic cells regulates Th17 cell development and experimental autoimmune encephalomyelitis in mice | Q34360200 | ||
Immune function of astrocytes | Q34398643 | ||
Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy | Q34486849 | ||
Unravelling mononuclear phagocyte heterogeneity | Q34546637 | ||
Interleukin-2 inhibits FMS-like tyrosine kinase 3 receptor ligand (flt3L)-dependent development and function of conventional and plasmacytoid dendritic cells | Q34572876 | ||
CD11c/EYFP transgene illuminates a discrete network of dendritic cells within the embryonic, neonatal, adult, and injured mouse brain | Q34590006 | ||
Steady-state and inflammatory dendritic-cell development | Q34591334 | ||
Macrophages as APC and the dendritic cell myth | Q34599073 | ||
Microglia and the control of autoreactive T cell responses | Q36499416 | ||
The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice | Q36512209 | ||
Timing and magnitude of type I interferon responses by distinct sensors impact CD8 T cell exhaustion and chronic viral infection | Q36611354 | ||
Role of nitric oxide in the regulation of T cell functions | Q36622372 | ||
Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells | Q36652900 | ||
The fate of plasma protein which escapes from blood vessels of the choroid plexus of the rat–an electron microscope study | Q36659621 | ||
Immune tolerance and control of CNS autoimmunity: from animal models to MS patients | Q36689189 | ||
Multifunctional antimicrobial peptides: therapeutic targets in several human diseases | Q36704656 | ||
Tolerogenic dendritic cells and the quest for transplant tolerance | Q36879029 | ||
An emerging role for galectins in tuning the immune response: lessons from experimental models of inflammatory disease, autoimmunity and cancer | Q36884492 | ||
IDO activates regulatory T cells and blocks their conversion into Th17-like T cells | Q36914732 | ||
Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells. | Q36915744 | ||
Lineage-specific transcription factors in unexpected places. | Q36924962 | ||
Defensin participation in innate and adaptive immunity | Q36990379 | ||
Creating immune privilege: active local suppression that benefits friends, but protects foes. | Q37026641 | ||
CD4-positive T cell-mediated neuroprotection requires dual compartment antigen presentation | Q37149908 | ||
Lymphoid chemokines in chronic neuroinflammation | Q37186200 | ||
Interactions among dendritic cells, macrophages, and epithelial cells in the gut: implications for immune tolerance. | Q37292796 | ||
Lymphatic drainage of the brain and the pathophysiology of neurological disease | Q37323411 | ||
T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase | Q37334065 | ||
The steady-state development of splenic dendritic cells | Q37349745 | ||
Differentiation and heterogeneity in the mononuclear phagocyte system | Q37349749 | ||
Regulatory myeloid suppressor cells in health and disease | Q37373257 | ||
Alarmins link neutrophils and dendritic cells | Q37399755 | ||
Alternative activation of macrophages: immune function and cellular biology | Q37407476 | ||
Astrocytes as potential targets to suppress inflammatory demyelinating lesions in multiple sclerosis | Q37697284 | ||
Deciphering the transcriptional network of the dendritic cell lineage | Q37700905 | ||
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. | Q37777431 | ||
The Blood–Cerebrospinal Fluid Barrier: Structure and Functional Significance | Q37810006 | ||
Endogenous lectins shape the function of dendritic cells and tailor adaptive immunity: mechanisms and biomedical applications. | Q37836094 | ||
P2 receptor signaling in neurons and glial cells of the central nervous system | Q37876548 | ||
Transcription factor networks in dendritic cell development. | Q37933760 | ||
Decisions about dendritic cells: past, present, and future | Q37963951 | ||
Lymphocyte signaling: regulation of FoxO transcription factors by microRNAs | Q37974991 | ||
Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy | Q37983043 | ||
CD33-related siglecs as potential modulators of inflammatory responses | Q37986851 | ||
Antigen presentation by endothelial cells: what role in the pathophysiology of malaria? | Q37988221 | ||
Development and homeostasis of "resident" myeloid cells: the case of the microglia | Q38030896 | ||
IL-17: a new actor in IFN-driven systemic autoimmune diseases | Q38040748 | ||
Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection | Q39187810 | ||
Activation of Toll-like receptors and dendritic cells by a broad range of bacterial molecules | Q39928593 | ||
Phosphorylated ITIMs enable ubiquitylation of an inhibitory cell surface receptor | Q40038804 | ||
Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. | Q40474320 | ||
Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study | Q40543264 | ||
Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis | Q41115305 | ||
Immune defence in mice lacking type I and/or type II interferon receptors | Q41126086 | ||
Species differences in the generation of reactive oxygen species by microglia | Q41167330 | ||
Failure of mature dendritic cells of the host to migrate from the blood into cardiac or skin allografts | Q41236939 | ||
Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. | Q41322007 | ||
Inhibitory effects of persistent apoptotic cells on monoclonal antibody production in vitro: simple removal of non-viable cells improves antibody productivity by hybridoma cells in culture | Q42118033 | ||
Progression of amyloid pathology to Alzheimer's disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2 | Q42132981 | ||
TLR3 and TLR4 are innate antiviral immune receptors in human microglia: role of IRF3 in modulating antiviral and inflammatory response in the CNS. | Q42155544 | ||
CD4(+) CD25(+) FoxP3(+) regulatory T cells suppress cytotoxicity of CD8(+) effector T cells: implications for their capacity to limit inflammatory central nervous system damage at the parenchymal level. | Q42575046 | ||
Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies. | Q43517448 | ||
Foxp3⁺ Treg cells in the inflamed CNS are insensitive to IL-6-driven IL-17 production. | Q43535189 | ||
Neogenesis of lymphoid structures and antibody responses occur in human melanoma metastases. | Q43785551 | ||
Plasmacytoid dendritic cells in multiple sclerosis: intracerebral recruitment and impaired maturation in response to interferon-beta | Q44098887 | ||
TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection | Q44308127 | ||
Activation of lysosomal function during dendritic cell maturation | Q44333919 | ||
Prevalence of dental caries and its correlation with the immunologic profile in HIV-Infected children on antiretroviral therapy. | Q44592847 | ||
Local type I IFN receptor signaling protects against virus spread within the central nervous system | Q45386700 | ||
Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9. | Q45987825 | ||
Abeta-specific T-cells reverse cognitive decline and synaptic loss in Alzheimer's mice. | Q46141854 | ||
Balancing function vs. self defense: the CNS as an active regulator of immune responses | Q46164320 | ||
Bone marrow-derived dendritic cells generated in the presence of resolvin E1 induce apoptosis of activated CD4+ T cells | Q46359155 | ||
Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids | Q46467408 | ||
The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells | Q46815019 | ||
Macrophages and dendritic cells in the rat meninges and choroid plexus: three-dimensional localisation by environmental scanning electron microscopy and confocal microscopy | Q47686882 | ||
The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis | Q47734606 | ||
Initial human myeloid/dendritic cell progenitors identified by absence of myeloperoxidase protein expression | Q47995469 | ||
Microglia can be induced by IFN-gamma or IL-4 to express neural or dendritic-like markers | Q48141249 | ||
Distribution and phenotype of dendritic cells and resident tissue macrophages in the dura mater, leptomeninges, and choroid plexus of the rat brain as demonstrated in wholemount preparations | Q48250691 | ||
Distribution of altered hippocampal neurons and axons immunoreactive with antisera against neuropeptide Y in Alzheimer's-type dementia | Q48333051 | ||
A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation | Q48349929 | ||
Intraepithelial and stromal dendritic cells in human choroid plexus | Q48370534 | ||
Inflammation in the CNS: balance between immunological privilege and immune responses | Q48402821 | ||
Stromal macrophages of the choroid plexus situated at an interface between the brain and peripheral immune system constitutively express major histocompatibility class II antigens | Q48424259 | ||
Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity | Q48487709 | ||
Bacillus Calmette-Guérin sequestered in the brain parenchyma escapes immune recognition | Q48495713 | ||
Maladaptation to mental stress mitigated by the adaptive immune system via depletion of naturally occurring regulatory CD4+CD25+ cells | Q48607462 | ||
Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier | Q48675893 | ||
Perivascular microglia defined | Q48913949 | ||
Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. | Q49014751 | ||
Brain dendritic cells and macrophages/microglia in central nervous system inflammation | Q49071798 | ||
CD11c-expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system. | Q50535079 | ||
Systemic inflammation and end organ damage following trauma involves functional TLR4 signaling in both bone marrow-derived cells and parenchymal cells. | Q50662068 | ||
Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferon-gamma primed mononuclear phagocytes. | Q50772565 | ||
CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE. | Q53015646 | ||
CCR7 essentially contributes to the homing of plasmacytoid dendritic cells to lymph nodes under steady-state as well as inflammatory conditions. | Q53269954 | ||
Origin of dendritic cells in peripheral lymphoid organs of mice. | Q53558035 | ||
Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. | Q53846430 | ||
Association of neuropeptides with Th1/Th2 balance and allergic sensitization in children. | Q54573052 | ||
Editorial | Q56879942 | ||
Harnessing dendritic cells | Q56880704 | ||
Distinct and Nonredundant In Vivo Functions of IFNAR on Myeloid Cells Limit Autoimmunity in the Central Nervous System | Q56984582 | ||
Recruitment of dendritic cells to the cerebrospinal fluid in bacterial neuroinfections | Q62065031 | ||
Migration patterns of dendritic cells in the mouse | Q68105591 | ||
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability | Q71615065 | ||
Monocyte-derived IL-10-secreting dendritic cells in choroid plexus epithelium | Q73608318 | ||
The immunophenotype of perivascular cells in the human brain | Q73878411 | ||
In vivo generation of human dendritic cell subsets by Flt3 ligand | Q74055026 | ||
Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS | Q34612865 | ||
Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox | Q34685501 | ||
Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology | Q34738708 | ||
Activation of interferon signaling pathways in spinal cord astrocytes from an ALS mouse model | Q34798823 | ||
Prostanoid signaling: dual role for prostaglandin E2 in neurotoxicity | Q34954633 | ||
Nitric oxide and redox mechanisms in the immune response | Q35001939 | ||
Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines | Q35082018 | ||
Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system? | Q35113121 | ||
Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain | Q35144558 | ||
Innate and adaptive immune responses to cell death. | Q35205885 | ||
Increased disease severity of parasite-infected TLR2-/- mice is correlated with decreased central nervous system inflammation and reduced numbers of cells with alternatively activated macrophage phenotypes in a murine model of neurocysticercosis | Q35329145 | ||
Alphavirus-induced encephalomyelitis: antibody-secreting cells and viral clearance from the nervous system | Q35363193 | ||
Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. | Q35553327 | ||
Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo | Q35669079 | ||
Interferon regulatory factor-7 modulates experimental autoimmune encephalomyelitis in mice. | Q35677443 | ||
In vivo expression of major histocompatibility complex molecules on oligodendrocytes and neurons during viral infection | Q35746926 | ||
Blockade of prostaglandin E2 signaling through EP1 and EP3 receptors attenuates Flt3L-dependent dendritic cell development from hematopoietic progenitor cells | Q35776979 | ||
Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. | Q35835489 | ||
Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors | Q35844406 | ||
Plasmacytoid dendritic cells transport peripheral antigens to the thymus to promote central tolerance | Q35861549 | ||
Heterogeneity of TLR-induced responses in dendritic cells: from innate to adaptive immunity | Q35916604 | ||
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase | Q35925641 | ||
Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage | Q36021817 | ||
Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression | Q36118293 | ||
Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation | Q36174679 | ||
When galectins recognize glycans: from biochemistry to physiology and back again | Q36196146 | ||
Cytokines in the induction and resolution of experimental autoimmune encephalomyelitis | Q36254007 | ||
Lamina propria dendritic cells in the physiology and pathology of the gastrointestinal tract | Q36284138 | ||
Role of vasoactive intestinal peptide in inflammation and autoimmunity. | Q36324402 | ||
Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors | Q36364985 | ||
A neuropeptide in immune-mediated inflammation, Y? | Q36418592 | ||
Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance | Q36426325 | ||
Dendritic cells in a mature age. | Q36475977 | ||
CNS dendritic cells: critical participants in CNS inflammation? | Q36491057 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | inflammation | Q101991 |
brain | Q1073 | ||
heterogeneity | Q928498 | ||
neuritis | Q2307256 | ||
encephalitis | Q199615 | ||
dendritic cell | Q506253 | ||
neuronitis | Q17157137 | ||
P304 | page(s) | 145-62 | |
P577 | publication date | 2013-03-01 | |
P1433 | published in | Journal of Neuroimmune Pharmacology | Q6295645 |
P1476 | title | Immune heterogeneity in neuroinflammation: dendritic cells in the brain | |
P478 | volume | 8 |
Q93133060 | A Characterization of Dendritic Cells and Their Role in Immunotherapy in Glioblastoma: From Preclinical Studies to Clinical Trials |
Q47638385 | Activation of pial and dural macrophages and dendritic cells by CSD (67 chrs). |
Q48132223 | Anti-inflammatory treatment of traumatic brain injury with Rabeximod reduces cerebral antigen presentation in mice |
Q26774826 | Are Microglial Cells the Regulators of Lymphocyte Responses in the CNS? |
Q36798288 | Astrocytes inhibit microglial surface expression of dendritic cell-related co-stimulatory molecules through a contact-mediated process |
Q89285825 | Dendritic Cells as an Alternate Approach for Treatment of Neurodegenerative Disorders |
Q38070093 | Dendritic cells and multiple sclerosis: disease, tolerance and therapy |
Q35000860 | Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND. |
Q34083673 | Interacting chemokine signals regulate dendritic cells in acute brain injury |
Q33717368 | LPS-induced systemic inflammation reveals an immunomodulatory role for the prion protein at the blood-brain interface |
Q39833593 | Microglia and monocyte-derived macrophages: functionally distinct populations that act in concert in CNS plasticity and repair |
Q36839851 | Microglial-neuronal interactions during neurodegenerative diseases |
Q26770676 | Myeloid Dendritic Cells are Potential Players in Human Neurodegenerative Diseases |
Q38078895 | Neural and immune mechanisms in the pathogenesis of Parkinson's disease. |
Q38957335 | Pathogenesis of cerebral palsy through the prism of immune regulation of nervous tissue homeostasis: literature review |
Q37364851 | Preoperative cerebrospinal fluid cytokine levels and the risk of postoperative delirium in elderly hip fracture patients |
Q48252543 | Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart |
Q64244146 | Role of Metabotropic Glutamate Receptors in Neurological Disorders |
Q28082878 | Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis |
Q37672845 | T Lymphocytes and Inflammatory Mediators in the Interplay between Brain and Blood in Alzheimer's Disease: Potential Pools of New Biomarkers |
Q89965531 | The Emerging Roles of Endoplasmic Reticulum Stress in Balancing Immunity and Tolerance in Health and Diseases: Mechanisms and Opportunities |
Q48186040 | Treatment of Dutch rat models of glioma using EphrinA1-PE38/GM-CSF chitosan nanoparticles by in situ activation of dendritic cells |
Q46132067 | Updates on immunity and inflammation in Parkinson disease pathology |
Search more.